Investfolio
≡
Home
Portfolio
Portfolio
Investments Overview
Blog
KAILERA THERAPEUTICS, INC.
KLRA
Exchange NMS, Currency in
Loading price...
Profit/Loss
PARTICULARS
TTM
2025
Operating Revenue
0.00
0.00
Operating Expenses
222.54M
158.34M
Profit after Tax (Net Income)
-209.84M
-148.96M